Eddy C Hsueh MD
Surgical Oncology (Other than Breast)
Professor in the Department of Surgery, Division of General Surgery, at Saint Louis University School of Medicine
Join to View Full Profile
3655 Vista AveSaint Louis, MO 63110
Phone+1 314-977-4440
Fax+1 314-977-1630
Dr. Hsueh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
SUNY Downstate Health Sciences UniversityResidency, Surgery, 1991 - 1996
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1996 - 2026
MO State Medical License 2003 - 2026
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 8 citationsBlocking senescence and tolerogenic function of dendritic cells induced by γδ Treg cells enhances tumor-specific immunity for cancer immunotherapy.Fusheng Si, Xia Liu, Yan Tao, Yuanqin Zhang, Feiya Ma
Journal for Immunotherapy of Cancer. 2024-04-05 - 2 citationsImpact of Hospital Volume on Utilization of Minimally Invasive Surgery for Gastric Cancer.Kristen Dougherty, Zidong Zhang, Grace Montenegro, Leslie Hinyard, Evan Xu
The American Surgeon. 2023-11-01 - 278 citationsNeoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.Sapna P Patel, Megan Othus, Yuanbin Chen, G Paul Wright Jr, Kathleen J Yost
The New England Journal of Medicine. 2023-03-02
Press Mentions
Newly Published Independent, Prospective Study Reinforces Prognostic Accuracy of DecisionDx-Melanoma in Cutaneous MelanomaApril 11th, 2019
Grant Support
- Enhancement Of Immunogenicity Of Human Melanoma VaccineNational Cancer Institute2003–2005
- Enhancement Of Immunogenicity Of Human Melanoma VaccineNational Cancer Institute2000–2003
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
